Renabec-FG Inhaler is a triple-combination inhalation therapy designed for the management of chronic respiratory conditions such as chronic obstructive pulmonary disease (COPD) and certain cases of severe asthma. It contains three active ingredients: Beclometasone Dipropionate, Formoterol Fumarate, and Glycopyrronium Bromide, which work together to reduce inflammation, relax airway muscles, and improve airflow in the lungs.

• Beclometasone Dipropionate is an inhaled corticosteroid that reduces inflammation in the airways, helping prevent asthma attacks and COPD exacerbations.

• Formoterol Fumarate is a long-acting beta-2 adrenergic agonist (LABA) that relaxes bronchial muscles, allowing easier airflow and improving breathing.

• Glycopyrronium Bromide is a long-acting muscarinic antagonist (LAMA) that further relaxes and opens the airways by blocking acetylcholine-mediated constriction.

The combination of these three agents in a single inhaler provides comprehensive bronchodilation, inflammation control, and symptom relief, reducing the frequency of exacerbations and improving overall lung function and quality of life for patients with chronic respiratory disease.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

Each puff of Renabec-FG Inhaler delivers:

• Beclometasone Dipropionate – 100 mcg

• Formoterol Fumarate – 6 mcg

• Glycopyrronium Bromide – 10 mcg

Mechanism of Action

Renabec-FG works through the complementary actions of its components:

• Beclometasone: Suppresses airway inflammation by reducing the production of inflammatory mediators, preventing swelling and mucus accumulation.

• Formoterol: Stimulates beta-2 adrenergic receptors in airway smooth muscle, causing relaxation and bronchodilation, which eases airflow.

• Glycopyrronium: Blocks muscarinic receptors in the lungs, preventing bronchoconstriction and maintaining open airways.

Together, these mechanisms help control chronic symptoms such as wheezing, shortness of breath, and coughing, while reducing the risk of flare-ups.

Indications

Renabec-FG Inhaler is prescribed for:

• Moderate to severe chronic obstructive pulmonary disease (COPD)

• Severe asthma uncontrolled with dual therapy

• Patients requiring triple inhaler therapy for long-term maintenance

• Prevention of frequent exacerbations in chronic respiratory disease

It is not intended for immediate relief of sudden asthma attacks; a short-acting rescue inhaler should be used in such cases.

Dosage and Administration

The dosage of Renabec-FG Inhaler should be individualized by a healthcare professional.

General usage instructions:

• Typical dose: 1–2 puffs twice daily, or as prescribed.

• Shake the inhaler well before each use.

• Exhale fully before inhaling, place the mouthpiece in your mouth, and inhale deeply while pressing the canister.

• Hold your breath for 5–10 seconds before exhaling.

• Rinse your mouth with water after use to reduce the risk of oral thrush from the corticosteroid.

Adherence to the prescribed regimen is essential for optimal control of chronic respiratory symptoms.

Possible Side Effects

Common side effects may include:

• Throat irritation or hoarseness

• Cough

• Dry mouth

• Tremors or palpitations

• Headache

Less common but serious side effects may include increased heart rate, urinary retention, or allergic reactions. Any severe or persistent symptoms require medical attention.

Precautions and Warnings

Before using Renabec-FG Inhaler, patients should inform their doctor if they have:

• Heart disease, arrhythmias, or high blood pressure

• Severe kidney or liver problems

• History of glaucoma or urinary retention

• Hypersensitivity to any of the components

This inhaler is intended for long-term maintenance therapy and should not replace rescue medication for sudden breathing difficulties.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Use in Pregnancy and Lactation

The inhaler should only be used during pregnancy or breastfeeding if clearly needed and prescribed by a physician. The benefits and potential risks should be carefully evaluated.

Storage

• Store below 30°C in a dry place

• Keep the inhaler upright and protected from direct sunlight

• Keep out of reach of children

Conclusion

Renabec-FG Inhaler (Beclometasone + Formoterol + Glycopyrronium) is a triple therapy inhaler for long-term management of COPD and severe asthma. By combining anti-inflammatory, bronchodilator, and antimuscarinic effects, it helps improve breathing, reduce symptoms, and prevent disease exacerbations. Regular use under medical guidance ensures effective and safe management of chronic respiratory conditions.